|
Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 661.44 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 669.00 °F. TCC ( 354.10 °C. ) (est)
|
| logP (o/w): | 18.579 (est) |
| Soluble in: |
| | water, 1.574e-013 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
| BOC Sciences |
| For experimental / research use only. |
| b-Amyrin palmitate > 95%
Odor: characteristic Use: ?-Amyrin palmitate isolated from the root of Periploca sepium Bung. It may release norepinephrine from newly synthesized pools to activate noradrenergic activity. And It has similar properties with mianserin in some respects, possessing a sedative action |
| Coompo |
| For experimental / research use only. |
| beta-Amyrin Palmitate from Plants ≥96%
Odor: characteristic Use: beta-Amyrin palmitate, like mianserin and imipramine, reduced the duration of immobility of mice significantly in a dose-dependent manner (5, 10 and 20 mg kg-1). beta-Amyrin palmitate (5, 10 and 20 mg kg-1) or mianserin (5, 10 and 20 mg kg-1) elicited a dose-related reduction in locomotor activity of mice and antagonized locomotor stimulation induced by methamphetamine. In contrast, imipramine (5, 10 and 20 mg kg-1) increased locomotor activity and potentiated methamphetamine-induced hyperactivity. beta-Amyrin palmitate showed no effect on reserpine-induced hypothermia, whilst mianserin (10 mg kg-1) and imipramine (10 and 20 mg kg-1) antagonized the reserpine-induced effect. beta-amyrin palmitate has similar properties in some respects to mianserin and might possess a sedative action.
beta-Amyrin palmitate might release norepinephrine from newly synthesized pools, and thus, it might activate noradrenergic activity. |
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | natural substances and extractives |
| Recommendation for amyrin palmitate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for amyrin palmitate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: | View |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 165382 |
| National Institute of Allergy and Infectious Diseases: | Data |
| | [(3S,6aR,6bS,8aR,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] hexadecanoate |
| Chemidplus: | 0005973068 |
References:
| | [(3S,6aR,6bS,8aR,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] hexadecanoate |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 165382 |
| Pubchem (sid): | 135121754 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| alpha- | amyrin palmitate | | [(3S,6aR,6bS,8aR,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b- | octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] hexadecanoate | | | olean-12-en-3-ol, hexadecanoate, (3b)- |
Articles:
|